Pharmacoequity in Older Patients With Inflammatory Bowel Disease.
作者信息
Kochar Bharati D
机构信息
Assistant Professor Harvard Medical School Massachusetts General Hospital Boston, Massachusetts.
出版信息
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):494-503.
Abstract
摘要
相似文献
1
Pharmacoequity in Older Patients With Inflammatory Bowel Disease.老年炎症性肠病患者的药物公平性
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):494-503.
2
Examining Pharmacoequity in Older Inflammatory Bowel Disease Patients.老年炎症性肠病患者的药物公平性研究。
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):435.
3
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.老年炎症性肠病患者的药物公平性
Clin Gastroenterol Hepatol. 2024 Feb;22(2):209-214. doi: 10.1016/j.cgh.2023.11.012.
4
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.老年炎症性肠病患者的药物公平性
Gastroenterology. 2024 Feb;166(2):235-239. doi: 10.1053/j.gastro.2023.12.005.
5
Pharmacoequity and Biologics in the Allergy Clinic: Providing the Right Care, at the Right Time, Every Time, to Everyone.药物经济学与过敏诊所中的生物制剂：每次都为每个人在恰当的时间提供恰当的护理。
J Allergy Clin Immunol Pract. 2024 May;12(5):1170-1180. doi: 10.1016/j.jaip.2024.02.039. Epub 2024 Mar 6.
6
Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress.追求药物公平：决定因素、驱动因素及前进途径
J Health Polit Policy Law. 2022 Dec 1;47(6):709-729. doi: 10.1215/03616878-10041135.
7
Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.过敏与免疫学中的药物公平性：美国及全球过敏性疾病药物获取方面的差异与建议解决方案
J Allergy Clin Immunol Pract. 2024 Feb;12(2):272-280. doi: 10.1016/j.jaip.2023.11.005. Epub 2023 Nov 10.
8
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.消除心房颤动、心力衰竭和血脂异常中的健康差异：实现药物平等的途径。
Curr Atheroscler Rep. 2023 Dec;25(12):1113-1127. doi: 10.1007/s11883-023-01180-5. Epub 2023 Dec 18.
9
Older people and inflammatory bowel disease: a systematic review.老年人与炎症性肠病：一项系统综述
J Clin Nurs. 2008 Nov;17(11c):400-6. doi: 10.1111/j.1365-2702.2008.02577.x.
10
The Experiences of Older Adults Living With Inflammatory Bowel Disease: A Scoping Review.老年炎症性肠病患者的经历：一项范围综述
Gastroenterol Nurs. 2023;46(4):296-308. doi: 10.1097/SGA.0000000000000737. Epub 2023 May 9.
本文引用的文献
1
Treatment of inflammatory bowel disease with steroid-sparing medications is age-dependent - Results from a Danish nationwide cohort study, 2000-2018.用激素保留药物治疗炎症性肠病具有年龄依赖性——来自 2000-2018 年丹麦全国队列研究的结果。
Aliment Pharmacol Ther. 2024 Aug;60(4):457-468. doi: 10.1111/apt.18106. Epub 2024 Jun 10.
2
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.老年炎症性肠病患者的药物公平性
Gastroenterology. 2024 Feb;166(2):235-239. doi: 10.1053/j.gastro.2023.12.005.
3
Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.美国炎症性肠病的发病率、患病率和种族与民族分布。
Gastroenterology. 2023 Nov;165(5):1197-1205.e2. doi: 10.1053/j.gastro.2023.07.003. Epub 2023 Jul 20.
4
Managing the older adult with inflammatory bowel disease: is age just a number?老年炎症性肠病患者的管理：年龄只是一个数字吗？
Curr Opin Gastroenterol. 2023 Jul 1;39(4):268-273. doi: 10.1097/MOG.0000000000000943. Epub 2023 May 23.
5
Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries-A nationwide cohort study.老年发病炎症性肠病患者使用各种药物治疗的机会减少，手术风险增加：一项全国性队列研究。
Aliment Pharmacol Ther. 2023 Jul;58(1):48-59. doi: 10.1111/apt.17520. Epub 2023 Apr 20.
6
The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis.老年病学在胃肠病学中的 5Ms：为患有炎症性肠病和肝硬化的老年患者创建友好型关怀的途径。
Clin Transl Gastroenterol. 2022 Jan 12;13(1):e00445. doi: 10.14309/ctg.0000000000000445.
7
Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.用于治疗炎症性肠病的药物随机对照试验中纳入和分析老年人的系统评价
Inflamm Bowel Dis. 2021 Aug 19;27(9):1541-1543. doi: 10.1093/ibd/izab052.
8
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review.美国胃肠病学会关于老年炎症性肠病管理的临床实践更新：专家综述
Gastroenterology. 2021 Jan;160(1):445-451. doi: 10.1053/j.gastro.2020.08.060. Epub 2020 Oct 1.
9
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey.胃肠病学家对老年溃疡性结肠炎患者使用免疫调节剂和生物疗法的偏好和风险认知：一项国际调查。
Eur J Gastroenterol Hepatol. 2020 Aug;32(8):976-983. doi: 10.1097/MEG.0000000000001768.
Zotero 插件